Differential involvement of glutathione S-transferase mu 1 and multidrug resistance protein 1 in melanoma acquired resistance to vinca alkaloids
Autor: | Chaker Attaoua, Qiang Bai, Kamel Hadj-Kaddour, Aida Abdel Jaoued, John De Vos, Laure-Anaïs Vincent, Laurence Vian, Pierre Cuq |
---|---|
Přispěvatelé: | Herrada, Anthony, Institut des Biomolécules Max Mousseron [Pôle Chimie Balard] (IBMM), Ecole Nationale Supérieure de Chimie de Montpellier (ENSCM)-Institut de Chimie du CNRS (INC)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Cellules Souches, Plasticité Cellulaire, Médecine Régénératrice et Immunothérapies (IRMB), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Centre National de la Recherche Scientifique (CNRS)-Institut de Chimie du CNRS (INC)-Université de Montpellier (UM)-Ecole Nationale Supérieure de Chimie de Montpellier (ENSCM), Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier) |
Jazyk: | angličtina |
Rok vydání: | 2015 |
Předmět: |
Vinca
Vindesine Pharmacology Biology glutathione S-transferases Vinblastine vinca alkaloids 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Multidrug Resistance Protein 1 Gene expression Tumor Cells Cultured medicine melanoma Humans Pharmacology (medical) neoplasms Glutathione Transferase 030304 developmental biology 0303 health sciences integumentary system Melanoma Vinorelbine Glutathione medicine.disease biology.organism_classification chemistry Drug Resistance Neoplasm Glutathione S-Transferase Mu Apoptosis 030220 oncology & carcinogenesis [SDV.SP.PHARMA] Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology Cancer research [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology Multidrug Resistance-Associated Proteins multidrug resistance proteins medicine.drug |
Zdroj: | Fundamental & Clinical Pharmacology Fundamental & Clinical Pharmacology, 2015, 29 (1), pp.62-71. ⟨10.1111/fcp.12093⟩ Fundamental and Clinical Pharmacology Fundamental and Clinical Pharmacology, Wiley, 2015, 29 (1), pp.62-71. ⟨10.1111/fcp.12093⟩ |
ISSN: | 0767-3981 1472-8206 |
Popis: | International audience; On account of its extreme intrinsic resistance to apoptosis and of its strong ability to become chemoresistant after a primary response to drugs, malignant melanoma (MM) is still a therapeutic challenge. We previously showed that glutathione S-transferase mu 1 (GSTM1) acts in synergy with multidrug resistance protein 1 (MRP1) to protect GSTM1-transfected human CAL1 melanoma cells from toxic effects of vincristine (VCR). Herein, we investigated the role of these proteins in the acquired resistance of CAL1 cells to vinca alkaloids (VAs). Resistant lines were established by continuous exposure (>1 year) of parental CAL1-wt cells to VCR, vindesine (VDS), or vinorelbine (VRB): CAL1R-VCR, CAL1R-VDS, CAL1R-VRB, respectively. All resistant lines displayed more than 10-fold increase in resistance to their selection VA, and specifically expressed GSTM1. Suggesting a direct interaction between this protein and VAs, each VA specifically decreased the GSTM1-mediated glutathione conjugation activity in cell lysates. Curcumin (GSTM1 inhibitor), BSO (glutathione synthesis inhibitor), and MK571 (MRP1 inhibitor) considerably reversed the acquired resistance to VCR and VDS, but not to VRB. Microarray data analysis revealed similar gene expression patterns of CAL1R-VCR and CAL1R-VDS, and a distinct one for CAL1R-VRB. These data suggest a differential involvement of GSTM1 and MRP1 in acquired resistance to VAs. A coordinated expression and activity of GSTM1 and MRP1 is required to protect CAL1 cells from VCR and VDS, while the simple expression of GSTM1 is sufficient, possibly by a direct drug/protein interaction, to confer resistance against VRB. |
Databáze: | OpenAIRE |
Externí odkaz: |